Insider Trading activities of Conatus Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Conatus Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Conatus Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Conatus Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is CNAT. The reporting company's CIK number is 1383701.
The total value of stock buying since 2005 is $17,206,485.
The total value of stock sales since 2005 is $31,966.
The total value of stock option exercises since 2005 is $132,718.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Conatus Pharmaceuticals Inc (CNAT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-01 0 $0 0 $0 42,424 $41,999
2016-12 0 $0 0 $0 41,414 $46,176
2016-10 0 $0 0 $0 18,181 $4,545
2015-04 4,000 $23,000 0 $0 0 $0
2014-01 0 $0 0 $0 12,121 $11,999
2013-09 0 $0 0 $0 12,121 $27,999
2013-07 1,562,135 $17,183,485 2,906 $31,966 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Conatus Pharmaceuticals Inc insiders (CNAT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-01-09 Cashion Charles (SVP, Finance, CFO and Sec.) Option Ex 42,424 .99 41,999
2016-12-20 Mento Steven J (President, CEO & Director) Option Ex 41,414 1.11 46,176
2016-10-27 Van Wart Harold (Director) Option Ex 18,181 .25 4,545
2015-04-08 Kisner Daniel L (Director) Buy 4,000 5.75 23,000
2014-01-08 Hale David F (Director) Option Ex 12,121 .99 11,999
2013-09-26 Hale David F (Director) Option Ex 12,121 2.31 27,999
2013-07-30 Cooperative Gilde Healthcare Ii U.a. (10% Owner) Buy 165,525 11.00 1,820,775
2013-07-30 Cooperative Gilde Healthcare Ii U.a. (10% Owner) Sale 352 11.00 3,872
2013-07-30 Mpm Asset Management Investors Bv5 Llc (10% Owner) Buy 165,265 11.00 1,817,915
2013-07-30 Perret Marc Olivier (Director) Buy 165,525 11.00 1,820,775
2013-07-30 Perret Marc Olivier (Director) Sale 352 11.00 3,872
2013-07-30 Malik Shahzad (Director) Buy 190,054 11.00 2,090,594
2013-07-30 Malik Shahzad (Director) Sale 535 11.00 5,885
2013-07-30 Vander Vort John (10% Owner) Buy 165,265 11.00 1,817,915
2013-07-30 Scopa James Paul (Director) Buy 165,265 11.00 1,817,915
2013-07-30 Aberdare Partners Iii Lp (10% Owner) Buy 107,422 11.00 1,181,642
2013-07-30 Aberdare Partners Iii Lp (10% Owner) Sale 566 11.00 6,226
2013-07-30 Mento Steven J (President, CEO & Director) Buy 13,800 11.00 151,800
2013-07-30 Advent Venture Partners Llp (10% Owner) Buy 190,054 11.00 2,090,594
2013-07-30 Advent Venture Partners Llp (10% Owner) Sale 535 11.00 5,885
2013-07-30 Lacasse Louis P (Director) Buy 123,950 11.00 1,363,450
2013-07-30 Hale David F (Director) Buy 2,588 11.00 28,468
2013-07-30 Klingenstein Paul H (Director) Buy 107,422 11.00 1,181,642
2013-07-30 Klingenstein Paul H (Director) Sale 566 11.00 6,226

Insider trading activities including stock purchases, stock sales, and option exercises of CNAT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Conatus Pharmaceuticals Inc (symbol CNAT, CIK number 1383701) see the Securities and Exchange Commission (SEC) website.